Skip to main content

Table 2 The comparison of glycemic parameters between patients with and without cardiovascular autonomic neuropathy

From: The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes

 

No CAN (n = 63)

CAN (n = 47)

p value

CGM parameters

   

  SD of glucose (mg/dL)

41.6 ± 15.0

51.7 ± 17.2

0.001

  MAGE (mg/dL)

89.4 ± 37.1

103.1 ± 37.1

0.061

  CV of glucose (%)

25.9 ± 7.9

30.1 ± 8.1

0.002

Mean glucose in CGM (mg/dL)

162.6 ± 47.4

172.2 ± 42.7

0.275

HbA1c variability over 2 years

   

 SD of HbA1c (%)

0.5 ± 0.3

0.8 ± 0.5

<0.001

  Adjusted SD of HbA1c (%)

0.4 ± 0.2

0.7 ± 0.4

<0.001

  CV of HbA1c

0.05 ± 0.04

0.09 ± 0.05

<0.001

Mean HbA1c over 2 years (%)

7.5 ± 1.0

8.4 ± 1.1

<0.001

  1. Data are mean ± SD
  2. Adjusted SD of HbA1c = SD of HbA1c/[n/(n–1)]0.5, where n is the number of HbA1c measurements
  3. CAN cardiovascular autonomic neuropathy, GV glycemic variability, CGM continuous glucose monitoring, MAGE mean amplitude of glycemic excursions, SD standard deviation, CV Coefficient of variance
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840